試す 金 - 無料
India's Apple-led electronics dream runs into China bump
Mint Mumbai
|July 09, 2025
India's ability to expand its assembly lines without Chinese technology experts is in question
Foxconn's recent recalls of key Chinese technology specialists from its Indian arm may hurt Apple's capacity to scale up the production of iPhones in India, hampering the country's ability to quickly boost its net earnings by churning out these high-end smartphones, government officials, industry executives, and analysts said.
Four people that Mint spoke with said while the withdrawals may not lead to a major disruption for Apple or Bharat Foxconn International Holdings Ltd (FIH), at stake is India's ability to expand its assembly lines without oversight from Chinese technology experts, partners and stakeholders.
For now, China's move appears to be restricted largely to Rising Stars Hi Tech—a wholly owned subsidiary of Foxconn's India unit, Bharat FIH, a senior government official said.
The "net" earnings from India's electronics industry, commonly referred to as "domestic value addition", refers to the industry's total contribution to India's economy—after paying all due royalties to foreign entities supplying the requisite infrastructure.
It is this that came under the scanner after Bloomberg reported on 2 July about China urging Taiwan's Foxconn to recall key executives—thus halting localization of technologies critical to expanding the electronics manufacturing ecosystem in India.
このストーリーは、Mint Mumbai の July 09, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Mint Mumbai からのその他のストーリー
Mint Mumbai
OTTs move past views, eye engagement metrics amid growth slowdown
On a video platform, every click may count as a view.
2 mins
January 13, 2026
Mint Mumbai
The Chinese company taking on the world's memory-chip giants
As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders
4 mins
January 13, 2026
Mint Mumbai
Pak’s conflict with Afghanistan opens $200 mn pharma window for India
Afghanistan’s border tensions with Pakistan, which led to the shutdown of vital transit routes, may have opened up a $200 million pharmaceutical opportunity for India.
2 mins
January 13, 2026
Mint Mumbai
BHEL stock slumps on China fears: Is the sell-off overdone?
Shares of public sector major Bharat Heavy Electricals Ltd (BHEL) have slid nearly 12% over the past three trading sessions, spooking investors after reports suggested a potential policy shift that could reopen India’s power equipment market to Chinese firms.
1 mins
January 13, 2026
Mint Mumbai
WHY VCS HAVE A NEW PLAYBOOK FOR DEEP-TECH
Venture capital has become more accessible while starting up, but is still scarce at the business end
8 mins
January 13, 2026
Mint Mumbai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Mumbai
Sukino bets $31 mn in post-hospital care
Venture capital and private equity investors are increasing the bets on post-hospital care-often referred to as 'continuum care' -as hospitals are discharging patients more quickly and families seek structured recovery outside hospitals.
2 mins
January 13, 2026
Mint Mumbai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Mint Mumbai
Five exercises to bring back into your routine
Try these moves to improve your strength, mobility and cardio health
2 mins
January 13, 2026
Mint Mumbai
Why khichdi, India's comfort food, beats every detox trend
Prepared with lentils and grains, this one-pot meal restores gut balance and offers comfort when the body needs rest most
3 mins
January 13, 2026
Listen
Translate
Change font size
